FDA
-
-
-
-
-
-
-
Cortigent presents 6-year study results for vision implant device
-
-
-
-
-
-
-
Vivani Medical Announces Filing of Form 10 Registration Statement for Planned Spin-Off of Cortigent Neurostimulation Business to Vivani Shareholders
-
-
-
-
-
-
-
Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business
-
-
-
-
-
-
-
Vivani Medical (VANI) Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant
-
-
-
-
-
-
-
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
-
-
-
-
-
-
-
Vivani Medical to Present at the Boulder Peptide Symposium
-
-
-
-
-
-
-
Vivani Medical Reports First Quarter Financial Results and Provides Business Update
-
325,856 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

